23 of 50
Johnson & Johnson
Johnson & Johnson
23
Top 50 rank: 23*
Rank in Pharmaceuticals: 4
(Previous rank: 5)
Overall score: 6.21
Ticker:JNJ

Why it's admired:
Stock prices for the world's largest seller of healthcare productsâÄîthe behemoth behind trusted classics like Band-Aids, Neutrogena, and ListerineâÄî reached record highs, jumping 7% in 2012. And that's despite the continued fall-out from a string of drug marketing issues and product recalls, most notably that of an artificial hip product that has put the company at the center of nearly 11,000 lawsuits and a Justice Department investigation. In 2012, the company was boosted by its acquisition of medical device maker Synthes, strong pharmaceutical sales, and its push into emerging markets. Johnson & Johnson's CEO Alex Gorsky has also stated his intention to keep the company more tightly focused on growth industries and market-leading businesses. âÄîEF

Headquarters:
New Brunswick, NJ
Website: www.jnj.com
Nine key attributes of reputation
Industry rank
Innovation
10
People management
3
Use of corporate assets
2
Social responsibility
1
Quality of management
6
Financial soundness
1
Long-term investment
1
Quality of products/services
11
Global competitiveness
4
From the March 18, 2013, issue.

Notes:
* Tied

The Most Admired list is the definitive report card on corporate reputations. Our survey partners at Hay Group started with approximately 1,400 companies: the Fortune 1,000âÄîthe 1,000 largest U.S. companies ranked by revenueâÄîand non-U.S. companies in Fortune's global 500 database with revenue of $10 billion or more... More